Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home Read more
AbbVie Submits BLA to FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis Read more
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata Read more
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD Read more
PhoenixMD Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND Read more